M&A Deal Summary |
|
|---|---|
| Date | 2017-08-03 |
| Target | 4path |
| Sector | Healthcare Services |
| Buyer(s) | Genesis Biotechnology Group |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
Genesis Biotechnology Group is a consortium of vertically integrated corporate research entities, which facilitates the overall market implementation and delivery of biomedical science products and services related to diagnostics and drug discovery.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 5 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 5 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 2 of 5 |
| Year: 2017 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-03-01 |
PharmOptima
Portage, Michigan, United States PharmOptima LLC is a drug discovery and development in various therapeutic areas and has filled a niche in ocular drug development. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-05 |
Comparative Biosciences
Sunnyvale, California, United States Comparative Biosciences, Inc. is specialized in GLP (Good Laboratory Practice) Toxicology and Safety Pharmacology projects for IND-enabling research studies. This portfolio addition will enable GD3 to expand its pre-clinical services to GLP based studies by (1) offering integrated, single-point-of-contact services throughout the project lifetime, (2) streamlining all phases of the discovery cycle and (3) enabling new discoveries to progress rapidly from project inception through pre-clinical development. Comparative Biosciences was founded in 1996 and is based in Sunnyvale, California. |
Buy | - |
